Optimization of Field Design in the Treatment of Rectal Cancer with Intensity Modulated Proton Beam Radiation Therapy: How Many Fields Are Needed to Account for Rectal Distension U...

by Jacob S. Parzen, MD, Weili Zheng, PhD, Xiaoqiang Li, PhD, Xuanfeng Ding, PhD, Peyman Kabolizadeh, MD, PhD
Published 2021-09-01

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation

by John M. David, MD, Yong Yue, PhD, Kevin Blas, MD, Andrew Hendifar, MD, Peyman Kabolizadeh, MD, Richard Tuli, MD PhD
Published 2019-10-01

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial

by Jacob S. Parzen, MD, Michael D. Chuong, MD, John Chang, MD, Lane Rosen, MD, James Urbanic, MD, William Hartsell, MD, Henry Tsai, MD, Christopher Sinesi, MD, Jing Zeng, MD, Mark Mishra, MD, Carlos Vargas, MD, Craig Stevens, MD, PhD, Peyman Kabolizadeh, MD, PhD
Published 2021-09-01